These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 31863513

  • 21. Thrombosis and risk factors in female patients with a rare acquired thrombophilia: chronic myeloproliferative disorder - polycythaemia vera and essential thrombocythaemia.
    Pósfai É, Marton I, Kiss-László Z, Kotosz B, Széll M, Borbényi Z.
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3810-8. PubMed ID: 25555871
    [Abstract] [Full Text] [Related]

  • 22. Polycythemia vera and essential thrombocythemia in young patients.
    Frezzato M, Ruggeri M, Castaman G, Rodeghiero F.
    Haematologica; 1993; 78(6 Suppl 2):11-7. PubMed ID: 8039752
    [Abstract] [Full Text] [Related]

  • 23. Association of monoclonal gammopathy and polycythemia vera or essential thrombocythemia: study of a large cohort of patients.
    Randi ML, Tison T, Ruzzon E, Pacquola E, Girolami A.
    Ann Hematol; 2003 Apr; 82(4):214-7. PubMed ID: 12707723
    [Abstract] [Full Text] [Related]

  • 24. Acute coronary disease in essential thrombocythemia and polycythemia vera.
    Rossi C, Randi ML, Zerbinati P, Rinaldi V, Girolami A.
    J Intern Med; 1998 Jul; 244(1):49-53. PubMed ID: 9698024
    [Abstract] [Full Text] [Related]

  • 25. Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea.
    Lim Y, Lee JO, Bang SM.
    J Korean Med Sci; 2016 Oct; 31(10):1579-85. PubMed ID: 27550486
    [Abstract] [Full Text] [Related]

  • 26. Target hematologic values in the management of essential thrombocythemia and polycythemia vera.
    Hernández-Boluda JC, Gómez M.
    Eur J Haematol; 2015 Jan; 94(1):4-11. PubMed ID: 24814134
    [Abstract] [Full Text] [Related]

  • 27. Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.
    Malak S, Labopin M, Saint-Martin C, Bellanne-Chantelot C, Najman A, French Group of Familial Myeloproliferative Disorders.
    Blood Cells Mol Dis; 2015 Jan; 49(3-4):170-6. PubMed ID: 22818858
    [Abstract] [Full Text] [Related]

  • 28. Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean Patients.
    Yoo EH, Park KJ, Won HH, Park JH, Park JH, Lee ST, Kim HJ, Bang SM, Chi HS, Jung CW, Kim SH, Yun H, Sun CH, Park I, Lee S, Lee C, Merriman B, Luo R, Tan EH, Park KJ, Yoo NK, Kang JJ, Kim JW.
    J Clin Lab Anal; 2016 Nov; 30(6):1061-1070. PubMed ID: 27132877
    [Abstract] [Full Text] [Related]

  • 29. Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia.
    Podoltsev NA, Wang R, Shallis RM, Stempel JM, Di M, Neparidze N, Zeidan AM, Huntington SF, Giri S, Hull SC, Gore SD, Ma X.
    Cancer Med; 2023 Sep; 12(18):18889-18900. PubMed ID: 37702132
    [Abstract] [Full Text] [Related]

  • 30. Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera.
    Karakantza M, Giannakoulas NC, Zikos P, Sakellaropoulos G, Kouraklis A, Aktypi A, Metallinos IC, Theodori E, Zoumbos NC, Maniatis A.
    Int J Hematol; 2004 Apr; 79(3):253-9. PubMed ID: 15168594
    [Abstract] [Full Text] [Related]

  • 31. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A.
    Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
    [Abstract] [Full Text] [Related]

  • 32. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera.
    Rottenstreich A, Kleinstern G, Krichevsky S, Varon D, Lavie D, Kalish Y.
    Eur J Intern Med; 2017 Jun; 41():49-54. PubMed ID: 27919526
    [Abstract] [Full Text] [Related]

  • 33. Coronary microvascular dysfunction due to essential thrombocythemia and policythemia vera: the missing piece in the puzzle of their increased cardiovascular risk?
    Vianello F, Cella G, Osto E, Ballin A, Famoso G, Tellatin S, Iliceto S, Cucchini U, Saggiorato G, Omenetto E, Tona F.
    Am J Hematol; 2015 Feb; 90(2):109-13. PubMed ID: 25352381
    [Abstract] [Full Text] [Related]

  • 34. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2011 Mar; 86(3):292-301. PubMed ID: 21351120
    [Abstract] [Full Text] [Related]

  • 35. How to Treat Essential Thrombocythemia and Polycythemia Vera.
    Besses C, Alvarez-Larrán A.
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S114-23. PubMed ID: 27521307
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.
    Ballen KK, Woolfrey AE, Zhu X, Ahn KW, Wirk B, Arora M, George B, Savani BN, Bolwell B, Porter DL, Copelan E, Hale G, Schouten HC, Lewis I, Cahn JY, Halter J, Cortes J, Kalaycio ME, Antin J, Aljurf MD, Carabasi MH, Hamadani M, McCarthy P, Pavletic S, Gupta V, Deeg HJ, Maziarz RT, Horowitz MM, Saber W.
    Biol Blood Marrow Transplant; 2012 Sep; 18(9):1446-54. PubMed ID: 22449610
    [Abstract] [Full Text] [Related]

  • 38. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia.
    Murphy S.
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):9-13. PubMed ID: 9930551
    [Abstract] [Full Text] [Related]

  • 39. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis.
    Passamonti F, Giorgino T, Mora B, Guglielmelli P, Rumi E, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Caramazza D, Merli M, Pietra D, Casalone R, Rotunno G, Barbui T, Cazzola M, Vannucchi AM.
    Leukemia; 2017 Dec; 31(12):2726-2731. PubMed ID: 28561069
    [Abstract] [Full Text] [Related]

  • 40. Contemporary approach to essential thrombocythemia and polycythemia vera.
    Aruch D, Mascarenhas J.
    Curr Opin Hematol; 2016 Mar; 23(2):150-60. PubMed ID: 26717193
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.